Dorzolamide Hydrochloride Ophthalmic Solution
Product Images NDC 71921-400

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Dorzolamide Hydrochloride Ophthalmic (NDC 71921-400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Florida Pharmaceutical Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dorzolamide-carton (Dorzolamide Carton)

The label for Dorzolamide Hydrochloride Ophthalmic Solution USP 2% (equivalent to 22.3 mg/mL Dorzolamide) features the product name prominently. It states the product is sterile, for ophthalmic use, and packaged in a 10 mL container. The label includes dosage information, storage instructions, manufacturer details (Florida Pharmaceutical Products, LLC; manufactured by Indoco Remedies Limited, India), and a barcode. The label also displays the NDC 71921-400-10 and the FPP logo.*

FDA Label Image

Dorzolamide-container (Dorzolamide Container)

Label for Dorzolamide Hydrochloride Ophthalmic solution 20 mg/mL (2%) by Florida Pharmaceutical Products, LLC. The 10 mL solution is prescription only, for use in eyes only, and should be protected from light. Manufactured by Indoco Remedies Limited, India. Contains barcode and lot/expiration placeholders.*

FDA Label Image

Dorzolamide-figa (Dorzolamide Figa)

An instructional diagram showing a bottle of ophthalmic solution labeled with parts including the cap, bottle, and tear-off tamper-evident ring. The figure is labeled as Fig. A and illustrates the components of the dropper bottle typically used for ophthalmic drug delivery.*

FDA Label Image

Dorzolamide-figb (Dorzolamide Figb)

An instructional line drawing showing a hand holding a bottle of ophthalmic solution and another hand removing or attaching a cap. The bottle has a dropper tip, intended for administering eye drops.*

FDA Label Image

Dorzolamide-figc (Dorzolamide Figc)

An instructional illustration showing a hand gripping an ophthalmic solution bottle and rotating its cap in a counterclockwise direction, demonstrating how to open the bottle. The figure is labeled 'Fig. C'.*

FDA Label Image

Dorzolamide-figd (Dorzolamide Figd)

An instructional line drawing showing a person tilting their head back and gently pulling down the lower eyelid to apply ophthalmic solution to the eye. The illustration depicts the correct technique for administering eye drops.*

FDA Label Image

Dorzolamide-fige (Dorzolamide Fige)

An instructional black-and-white line drawing illustrating the proper technique for administering ophthalmic drops. The image shows a person tilting their head back, holding an eye drop bottle above the eye, and pulling down the lower eyelid to create a pocket for the drops.*

FDA Label Image

Dorzolamide-structure (Dorzolamide Structure)

Chemical structure of Dorzolamide Hydrochloride, showing its molecular framework including sulfonamide, thiophene, and hydrochloride components as represented in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.